Novartis not joining the 'frenzy' of weight loss drugs, CEO says
Swiss pharmaceutical giant Novartis said Wednesday that it does not plan to enter into the "frenzy" of weight loss drugs.
This Big Move by Eli Lilly May Solve the Weight Loss Drug Market's Biggest Problem
In fact, demand has been so high that it's been surpassing supply, forcing Lilly and rival Novo Nordisk to invest in additional manufacturing capacity. Recently, Lilly made a new move that could solve this supply issue -- the biggest problem facing these drug makers -- and boost Lilly's already strong earnings.
Health Rounds: Next generation Lilly weight-loss drug shows added heart, liver benefits
Eli Lilly's experimental next generation weight-loss drug mimics three hormones instead of just one or two and continues to show promising clinical trial results for additional health benefits, the company said.
Healthy Returns: How competitive can Roche be in the weight loss drug market?
Roche presented early-stage data on its obesity injection and pill at EASD. Meanwhile, Oura enters into metabolic health market with acquisition of Veri.
Weight-loss drug competition heats up with growing pill market
The weight-loss market is heating up as a number of companies are looking for a way to upend the dominance of market leaders Novo Nordisk ( NVO) and Eli Lilly ( LLY) by introducing GLP-1 pills.
New Weight Loss Drug Has Small Problem: Uncontrollable Vomiting
A Swiss pharmaceutical company hoping to cash in on the weight loss drug trend is having its dreams dashed amid new trials showing that the drugs cause most people to yak. As the Financial Times reports,
New York Post21d
Eli Lilly slashes price of weight-loss drug Zepbound by 50% to sell in smaller doses
Eli Lilly said it has started selling single-dose vials of its uber-popular weight-loss drug Zepbound as demand soars – and the smaller doses cost 50% less than rival drugs. The more ...
GLP-1 pills are coming, and they could revolutionize weight-loss treatment
At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, ...
The Washington Post18d
Eli Lilly ramps up its fight against imitation weight-loss drugs
Eli Lilly and rival Novo Nordisk have been battling the emerging industry making copies of their top-selling diabetes and weight-loss drugs, a situation without modern precedent. It started in ...
USA Today29d
Lilly weight loss drug prevents diabetes, company says
Drug giant Eli Lilly says its weight-loss drug tirzepatide helps people with obesity avoid getting diabetes, even months after stopping the medication. Excess weight increases the risk for ...
Forget Mounjaro: 1 Reason Investors Should Love Eli Lilly Stock Even More (Hint: I'm Not Talking About Zepbound)
Forget Mounjaro: 1 Reason Investors Should Love Eli Lilly Stock Even More (Hint: I'm Not Talking About Zepbound) ...
CBS News20d
Eli Lilly slashes prices of weight-loss drug Zepbound for single-use vials
Drugmaker Eli Lilly said Tuesday it will sell single-use vials of its weight-loss drug Zepbound at a fraction of the price of its pens, amid skyrocketing demand among Americans for ...
USA Today21d
Eli Lilly launches new version of its popular weight loss drug at a discount
Eli Lilly said it has begun selling vials of the smallest, starter dose of its popular weight-loss drug Zepbound in the United States for $399 for a month on its direct-to-consumer website to ...